You are here

Novo Nordisk

GLP-1 Agonists, Like Ozempic and Wegovy, Have Risk of Gut Issues: Study

BioSpace

Thu, 10/5/23 - 09:07 pm

At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide

Fierce Pharma

Thu, 10/5/23 - 10:21 am

US Patent Office won't review two Novo Nordisk patents for Wegovy, Ozempic

Yahoo/Reuters

Tue, 10/3/23 - 07:35 pm

With FDA nod for rare disease drug Rivfloza, Novo Nordisk eyes showdown with Alnylam

Fierce Pharma

Mon, 10/2/23 - 06:36 pm

primary hyperoxaluria type 1

Novo Nordisk challenges CMS drug price negotiations, then signs on to the program

Fierce Pharma

Mon, 10/2/23 - 11:56 am

Inflation Reduction Act

FDA Adds New Warning for Ileus to Ozempic Label

HCP Live

Thu, 09/28/23 - 11:55 am

Novo Nordisk, Evotec partner in metabolic disease drug discovery pact

BioPharma Dive

Tue, 09/26/23 - 09:51 pm

metabolic diseases

Novo Nordisk and Valo to research cardiometabolic treatments

Reuters

Mon, 09/25/23 - 10:16 am

artificial intelligence

cardiometabolic diseases

Obesity Drug Market Set to Hit $100 Billion by 2035, BMO Says

Yahoo/Bloomberg

Sun, 09/24/23 - 08:56 pm

Why a hidden message in Ozempic’s logo represents a big shift in drug branding

Fast Company

Fri, 09/22/23 - 12:03 pm

Novo Nordisk Foundation to establish €127 million cell therapy plant

Biopharma Reporter

Thu, 09/21/23 - 06:39 pm

Why Novo Nordisk Stock Edged Higher Today

Motley Fool

Wed, 09/20/23 - 11:06 pm

drug manufacturing

Inside the FDA's Form 483 findings at Novo Nordisk's North Carolina semaglutide plant

Fierce Pharma

Tue, 09/19/23 - 10:19 pm

drug manufacturing

Novo Nordisk taps Aspen to help produce insulin for Africa

Fierce Pharma

Tue, 09/19/23 - 10:49 am

Aspen Pharmacare

drug manufacturing

Novo Nordisk Dives After FDA Reportedly Finds 'Objectionable' Conditions At A Key Wegovy Plant

Investors Business Daily

Mon, 09/18/23 - 07:58 pm

drug manufacturing

Novo Nordisk hires private U.S. firm to handle some Wegovy pen assembly

Reuters

Mon, 09/18/23 - 12:35 pm

PCI Pharma Services

drug manufacturing

Ozempic-Maker Invests in Renewables

Daily Upside

Thu, 09/14/23 - 11:06 pm

renewable energy

Novo, Lilly set to dominate $71B GLP-1 drug market by 2032: J.P. Morgan

Fierce Pharma

Mon, 09/11/23 - 12:26 pm

After treatment with semaglutide, people with newly diagnosed type 1 diabetes needed little or no insulin

Medical News Today

Sun, 09/10/23 - 08:03 pm

type 1 diabetes

Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts

Fierce Pharma

Fri, 09/8/23 - 10:29 am

Pages